Australian Clinical Labs Past Earnings Performance
Past criteria checks 1/6
Australian Clinical Labs has been growing earnings at an average annual rate of 3.2%, while the Healthcare industry saw earnings growing at 1.5% annually. Revenues have been growing at an average rate of 3.7% per year. Australian Clinical Labs's return on equity is 9.5%, and it has net margins of 2.3%.
Key information
3.2%
Earnings growth rate
-17.7%
EPS growth rate
| Healthcare Industry Growth | 2.4% |
| Revenue growth rate | 3.7% |
| Return on equity | 9.5% |
| Net Margin | 2.3% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Australian Clinical Labs makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 674 | 15 | 0 | 0 |
| 30 Sep 23 | 686 | 26 | 0 | 0 |
| 30 Jun 23 | 697 | 36 | 0 | 0 |
| 31 Mar 23 | 757 | 55 | 0 | 0 |
| 31 Dec 22 | 818 | 73 | 0 | 0 |
| 30 Sep 22 | 907 | 126 | 0 | 0 |
| 30 Jun 22 | 996 | 178 | 0 | 0 |
| 31 Mar 22 | 931 | 156 | 1 | 0 |
| 31 Dec 21 | 867 | 134 | 2 | 0 |
| 30 Sep 21 | 757 | 97 | 2 | 0 |
| 30 Jun 21 | 647 | 60 | 2 | 0 |
| 31 Mar 21 | 598 | 79 | 1 | 0 |
| 31 Dec 20 | 549 | 98 | 0 | 0 |
| 30 Sep 20 | 520 | 70 | 0 | 0 |
| 30 Jun 20 | 491 | 41 | 0 | 0 |
| 30 Jun 19 | 448 | -11 | 315 | 0 |
| 30 Jun 18 | 379 | -9 | 267 | 0 |
| 30 Jun 17 | 340 | -24 | 252 | 0 |
Quality Earnings: ACL has a large one-off loss of A$13.7M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: ACL's current net profit margins (2.3%) are lower than last year (9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ACL has become profitable over the past 5 years, growing earnings by 3.2% per year.
Accelerating Growth: ACL's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ACL had negative earnings growth (-79%) over the past year, making it difficult to compare to the Healthcare industry average (-19.1%).
Return on Equity
High ROE: ACL's Return on Equity (9.5%) is considered low.